h1

h2

h3

h4

h5
h6


001     478837
005     20201223144436.0
024 7 _ |a 10.1007/s00213-014-3794-9
|2 doi
024 7 _ |a WOS:000352786900010
|2 WOS
024 7 _ |a pmid:25373869
|2 pmid
024 7 _ |a PREV201500419829
|2 BIOSIS
024 7 _ |a 0033-3158
|2 ISSN
024 7 _ |a 1432-2072
|2 ISSN
024 7 _ |a SCOPUS:2-s2.0-84939938916
|2 SCOPUS
037 _ _ |a RWTH-2015-02733
041 _ _ |a English
082 _ _ |a 610
100 1 _ |0 P:(DE-82)076647
|a Veselinovic, Tanja
|b 0
|e Corresponding author
245 _ _ |a Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers
|h online, print
260 _ _ |a Berlin
|b Springer
|c 2015
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |2 DRIVER
|a article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
588 _ _ |a Dataset connected to CrossRef
591 _ _ |a Germany
700 1 _ |a Vernaleken, Ingo
|0 P:(DE-82)014516
|b 1
700 1 _ |a Janouschek, Hildegard
|0 P:(DE-82)019279
|b 2
700 1 _ |a Kellermann, Thilo
|0 P:(DE-82)IDM03646
|b 3
|u rwth
700 1 _ |a Paulzen, Michael
|0 P:(DE-82)028941
|b 4
700 1 _ |a Cumming, Paul
|0 P:(DE-82)052424
|b 5
700 1 _ |a Gründer, Gerhard
|0 P:(DE-82)012827
|b 6
773 _ _ |0 PERI:(DE-600)2066933-1
|a 10.1007/s00213-014-3794-9
|n 9
|p 1607-1617
|t Psychopharmacology
|v 232
|x 1432-2072
|y 2015
909 C O |o oai:publications.rwth-aachen.de:478837
|p VDB
914 1 _ |y 2015
915 1 _ |0 StatID:(DE-HGF)0031
|2 HGFVOC
|a Peer reviewed article
|x 0
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b PSYCHOPHARMACOLOGY : 2014
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0310
|2 StatID
|a DBCoverage
|b NCBI Molecular Biology Database
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
915 _ _ |0 StatID:(DE-HGF)0420
|2 StatID
|a Nationallizenz
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b PSYCHOPHARMACOLOGY : 2015
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
920 1 _ |0 I:(DE-82)535500-2_20140620
|k 535500-2
|l Lehrstuhl für Psychiatrie, Psychotherapie und Psychosomatik
|x 0
920 1 _ |0 I:(DE-82)535500-4_20140620
|k 535500-4
|l Lehr- und Forschungsgebiet Experimentelle Psychopathologie
|x 1
920 1 _ |0 I:(DE-82)535500-3_20140620
|k 535500-3
|l Lehr- und Forschungsgebiet Experimentelle Neuropsychiatrie
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-82)535500-2_20140620
980 _ _ |a I:(DE-82)535500-4_20140620
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-82)535500-3_20140620


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21